INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $251,000 | -13.4% | 185,871 | 0.0% | 0.00% | – |
| Q3 2016 | $290,000 | +16.9% | 185,871 | -0.4% | 0.00% | – |
| Q2 2016 | $248,000 | -73.2% | 186,575 | +6.0% | 0.00% | -100.0% |
| Q1 2016 | $927,000 | -32.2% | 175,980 | +1.1% | 0.00% | -50.0% |
| Q4 2015 | $1,367,000 | -6.4% | 174,092 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,460,000 | -23.4% | 172,757 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $1,905,000 | -3.9% | 173,975 | +22.7% | 0.00% | -33.3% |
| Q1 2015 | $1,982,000 | -16.3% | 141,774 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,367,000 | +25.2% | 140,131 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,890,000 | +5.4% | 140,853 | +0.0% | 0.00% | +50.0% |
| Q2 2014 | $1,794,000 | +13.6% | 140,791 | +6.0% | 0.00% | 0.0% |
| Q1 2014 | $1,579,000 | -13.4% | 132,780 | +0.6% | 0.00% | -33.3% |
| Q4 2013 | $1,823,000 | -22.4% | 131,993 | -2.1% | 0.00% | -25.0% |
| Q3 2013 | $2,350,000 | +14.8% | 134,826 | +6.6% | 0.00% | 0.0% |
| Q2 2013 | $2,047,000 | – | 126,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |